AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 123 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | -80.0% | 29,526 | -6.3% | 0.00% | – |
Q2 2022 | $5,000 | -64.3% | 31,526 | 0.0% | 0.00% | – |
Q1 2022 | $14,000 | -26.3% | 31,526 | -6.2% | 0.00% | – |
Q4 2021 | $19,000 | -67.8% | 33,626 | -5.6% | 0.00% | – |
Q3 2021 | $59,000 | 0.0% | 35,626 | 0.0% | 0.00% | – |
Q2 2021 | $59,000 | 0.0% | 35,626 | +1.7% | 0.00% | – |
Q1 2021 | $59,000 | +7.3% | 35,044 | 0.0% | 0.00% | – |
Q4 2020 | $55,000 | +77.4% | 35,044 | +6.1% | 0.00% | – |
Q3 2020 | $31,000 | +138.5% | 33,044 | +57.4% | 0.00% | – |
Q2 2020 | $13,000 | +62.5% | 20,996 | 0.0% | 0.00% | – |
Q1 2020 | $8,000 | +14.3% | 20,996 | +69.3% | 0.00% | – |
Q4 2019 | $7,000 | 0.0% | 12,400 | -21.2% | 0.00% | – |
Q3 2019 | $7,000 | +16.7% | 15,734 | 0.0% | 0.00% | – |
Q2 2019 | $6,000 | +20.0% | 15,734 | +52.3% | 0.00% | – |
Q1 2019 | $5,000 | -96.6% | 10,334 | -71.7% | 0.00% | -100.0% |
Q4 2017 | $149,000 | – | 36,546 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 291,500 | $137,000 | 0.14% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $441,000 | 0.14% |
CVA Family Office, LLC | 1,137,920 | $535,000 | 0.13% |
Cypress Capital Management LLC (WY) | 179,525 | $84,000 | 0.10% |
Willis Investment Counsel | 2,075,840 | $976,000 | 0.05% |
NTB Financial Corp | 146,100 | $69,000 | 0.05% |
SRS Capital Advisors, Inc. | 629,172 | $296,000 | 0.04% |
Helen Stephens Group, LLC | 117,222 | $55,000 | 0.04% |
COURIER CAPITAL LLC | 464,356 | $218,000 | 0.02% |
Western Wealth Management, LLC | 946,800 | $444,000 | 0.02% |